MetabolicInvestigational

Taspoglutide

Subcutaneous injection

Overview

Taspoglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist derived from human GLP-1 with amino acid substitutions designed to resist dipeptidyl peptidase-4 degradation and extend duration of action. The peptide activates pancreatic GLP-1 receptors to promote glucose-dependent insulin secretion, inhibit glucagon release, and slow gastric emptying.

Mechanism of Action

Its structural modifications were intended to support once-weekly administration for the treatment of type 2 diabetes mellitus..

Research Summary & Key Findings

Phase 3 clinical trials (T-emerge program) demonstrated efficacy in glycemic control and weight reduction, with results published in Diabetes Care and related journals between 2010 and 2011. Development was discontinued in 2010 due to concerns over injection site reactions and gastrointestinal tolerability despite meeting primary efficacy endpoints, and the compound never received regulatory approval.

Clinical Status

Investigational

Taspoglutide is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Subcutaneous injection

Related Peptides in Metabolic

Semaglutide (Ozempic/Wegovy)

FDA Approved

A glucagon-like peptide-1 receptor agonist (GLP-1 RA) with 94% amino acid homology to native GLP-1. Semaglutide enhances...

View details

Tirzepatide (Mounjaro/Zepbound)

FDA Approved

A first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Tirzepatide activat...

View details

Retatrutide

In Clinical Trials

An investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The gluc...

View details

AOD-9604

Investigational

A modified 16-amino acid fragment (amino acids 176-191) of the C-terminus of human growth hormone with an added tyrosine...

View details

Find a Provider

Find a verified provider who offers Taspoglutide therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Taspoglutide.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.